BNP Paribas Financial Markets
APEN

BNP Paribas Financial Markets’s Apollo Endosurgery, Inc. APEN Stock Holding History

BNP Paribas Financial Markets’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500
Closed -$2.75K – 4872
2022
Q3 		$2.75K Buy
+500
New +$2.77K ﹤0.01% 4314

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets's APEN Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 500 shares — an estimated $2.75K sold.

BNP Paribas Financial Markets first reported a position in APEN in Q3 2022 and held it in 1 quarter. The position peaked at $2.75K in Q3 2022. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 500 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $2.75K.
  • BNP Paribas Financial Markets first reported a position in Apollo Endosurgery, Inc. in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Apollo Endosurgery, Inc. position peaked at $2.75K in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.